| Dexamethasone in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 384 (8), 693-704, 2021 | 2759 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1747* | 2021 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1446 | 2020 |
| Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ... The Lancet 396 (10259), 1345-1352, 2020 | 793 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 369* | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Cryptococcal meningitis: epidemiology and therapeutic options DJ Sloan, V Parris Clinical epidemiology, 169-182, 2014 | 314 | 2014 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 233 | 2022 |
| The role of delamanid in the treatment of drug-resistant tuberculosis JM Lewis, DJ Sloan Therapeutics and clinical risk management, 779-791, 2015 | 112 | 2015 |
| Linezolid for drug‐resistant pulmonary tuberculosis B Singh, D Cocker, H Ryan, DJ Sloan Cochrane Database of Systematic Reviews, 2019 | 108 | 2019 |
| Hepatitis B virus infection as a neglected tropical disease GA O’Hara, AL McNaughton, T Maponga, P Jooste, P Ocama, R Chilengi, ... PLoS neglected tropical diseases 11 (10), e0005842, 2017 | 105 | 2017 |
| Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource‐limited settings D Sloan, S Dlamini, N Paul, M Dedicoat Cochrane Database of Systematic Reviews, 2008 | 94 | 2008 |
| A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi C Rothe, DJ Sloan, P Goodson, J Chikafa, M Mukaka, B Denis, T Harrison, ... PloS one 8 (6), e67311, 2013 | 90 | 2013 |
| Pharmacodynamic modeling of bacillary elimination rates and detection of bacterial lipid bodies in sputum to predict and understand outcomes in treatment of pulmonary tuberculosis DJ Sloan, HC Mwandumba, NJ Garton, SH Khoo, AE Butterworth, ... Clinical infectious diseases 61 (1), 1-8, 2015 | 81 | 2015 |
| Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis NA Feasey, PP Banada, W Howson, DJ Sloan, A Mdolo, C Boehme, ... Journal of clinical microbiology 51 (7), 2311-2316, 2013 | 76 | 2013 |
| A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200mg oral fluconazole in Blantyre, Malawi KM Gaskell, C Rothe, R Gnanadurai, P Goodson, C Jassi, RS Heyderman, ... PloS one 9 (11), e110285, 2014 | 73 | 2014 |
| Healthcare‐seeking behaviour and use of traditional healers after snakebite in Hlabisa sub‐district, KwaZulu Natal DJ Sloan, MJ Dedicoat, DG Lalloo Tropical Medicine & International Health 12 (11), 1386-1390, 2007 | 64 | 2007 |
| Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings DJ Sloan, JM Lewis Transactions of the Royal Society of Tropical Medicine and Hygiene 110 (3 …, 2016 | 62 | 2016 |
| Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis molecular bacterial load assay W Sabiiti, K Azam, ECW Farmer, D Kuchaka, B Mtafya, R Bowness, ... Thorax 75 (7), 606-608, 2020 | 61 | 2020 |
| Population pharmacokinetics and Bayesian dose adjustment to advance TDM of anti-TB drugs MGG Sturkenboom, AG Märtson, EM Svensson, DJ Sloan, KE Dooley, ... Clinical pharmacokinetics 60, 685-710, 2021 | 59 | 2021 |
